Kura Oncology And Kyowa Kirin Report Encouraging Long-Term Results for Ziftomenib / 7+3 Combination In Newly Diagnosed AML

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. ABBV
2. MU
3. ACN
4. IBM
5. PRIM
6. META
7. DPZ
8. N2EW34
9. INTC
10. IMNN

Go back to Kura Oncology And Kyowa Kirin Report Encouraging Long-Term Results for Ziftomenib / 7+3 Combination In Newly Diagnosed AML
Kirin Holdings Company, Limited Sponsored ADR (AMEX: KNBWY) Delayed: 17.45 --0 (-0%)
Previous Close $17.45    52 Week High $18.64 
Open $17.45    52 Week Low $12.59 
Day High $17.45    P/E N/A 
Day Low $17.45    EPS $0.00 
Volume 10,000       

(NASDAQ: KURA) Delayed: 10.36 --0 (-0%)
Previous Close $10.36    52 Week High $8.90 
Open $10.36    52 Week Low $2.50 
Day High $10.36    P/E N/A 
Day Low $10.36    EPS $0.00 
Volume 3,416       

(AMEX: KYKOY) Delayed: 15.58 --0 (-0%)
Previous Close $15.58    52 Week High $ 
Open $15.58    52 Week Low $ 
Day High $15.58    P/E N/A 
Day Low $15.58    EPS $ 
Volume 1